Placental dysfunction and impaired fetal growth: a relationship with bronchopulmonary dysplasia and pulmonary hypertension

Karen Young,Ilene Sosenko,Nelson Claure

DOI: https://doi.org/10.1136/thoraxjnl-2021-217476

2021-08-24

Thorax

Abstract:More than five decades ago, Northway et al1 described the clinical, radiological and pathological features of a chronic lung disease in preterm infants characterised by lung emphysema, fibrosis, pulmonary vascular remodelling and cardiac hypertrophy.1 At that time, this chronic lung disease of prematurity, which they named bronchopulmonary dysplasia (BPD), was thought to occur as a consequence of postnatal events, including severe respiratory distress syndrome, oxygen toxicity and volutrauma.1 Despite improvements in neonatal care, postnatal adverse exposures continue to be important factors in BPD pathogenesis. Emerging evidence also suggests that pulmonary outcomes after preterm birth are likely determined not only by postnatal factors but also by the in utero environment. Male gender, white race, smoking, hypertension and infection have all been linked to increased BPD susceptibility. In addition, growing evidence suggests that fetal growth restriction (FGR) is a major risk factor for BPD.

respiratory system